On November 28, the capital of Belgium hosted the annual Kyiv Investment Forum, which is a platform for discussing the implementation of projects and attracting investments. This year, Kyiv’s post-war reconstruction is in the spotlight in three key aspects: resilience, innovation, and sustainable development.
The capital of Ukraine is the center of the pharmaceutical industry. In addition to the industry leader Farmak, other key manufacturers with extensive experience, professional teams, and advanced technologies are also located here. In addition, this summer the pharmaceutical industry was recognized as one of the 7 priority sectors of the Ukrainian economy. This means that now the state will actively support projects for the development and attraction of investments for pharmaceutical production.
“During the recovery of Ukraine, it is especially important to focus on industries with high added value, on smart industries. And until February 24, the IT sector was in the spotlight in Ukraine. Ukrainians have achieved success in this, Kyiv has become a major hub for IT ideas. I can say that the pharmaceutical industry, which uses advanced IT solutions in its production and R&D, has no less potential than the information technology sector,” says Farmak Director for Corporate Communications Yevgeniya Piddubna.
First during the pandemic, and now during the war in Ukraine, we have seen how important it is to have a highly developed healthcare system, and, of course, access to medicines – physical and financial. The only way to do this is to develop a strong and independent pharmaceutical industry within the country.
In order to guarantee the resilience, innovation, and sustainable development of Kyiv and Ukraine as a whole, it is important today, when planning the post-war reconstruction, to focus on knowledge-intensive and high-tech industries. We are sure that the pharmaceutical industry should become one of them.
On January 18, 2023, the Economic Court of Cassation as part of the Supreme Court, on a cassation appeal from Pharmaceutical Firm Darnitsa, overturned the decision of the Appeal Chamber of the Ministry of Economic Development to recognize Corvalol Corvalolum as the well-known trademark of Farmak JSC. Previously, the Northern Economic Court of Appeal in [&hel...
Farmak remains the largest pharmaceutical company in Ukraine. In 2022, the company paid more than UAH 870 million to the state budget in the form of taxes and fees, moreover, it did it ahead of schedule in order to support the country’s economy. Despite the fact that the russians destroyed the company’s warehouses with all […]
Since September 2022, Farmak has held three workshops on the basics of echocardiography for physicians, which were attended mainly by cardiologists and family doctors. Echocardiography or ultrasound of the heart is the most informative and safe research method, during which the doctor gets a complete picture of the structure and functioning of the heart and ...